Novo Nordisk Calls On Two Flagship Firms For Early Science In Metabolic Health

 
• By Joseph Haas

Derived from a 2022 collaboration between the two, Novo Nordisk will partner with Flagship-backed Omega in obesity and Cellarity in NASH. Both programs are in very early stages at present.

Novo Nordisk HQ
Novo Nordisk has inked the first two deals under its Flagship alliance • Source: Shutterstock

More from Deals

More from Business